Biogen Inc. 13D and 13G filings for Reata Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-09-28 4:38 pm Sale |
2023-09-26 | 13D | Reata Pharmaceuticals, Inc. RETA |
BIOGEN IDEC INC BIIB |
0 0.000% |
-8,936,791 (Position Closed) |
Filing |
| 2023-08-07 5:21 pm Purchase |
2023-07-28 | 13D | Reata Pharmaceuticals, Inc. RETA |
BIOGEN IDEC INC BIIB |
8,936,791 23.400% |
8,936,791 (New Position) |
Filing |